Josef Finsterer, MD, PhD*, Marlies Frank, MD. Evidence level for effectiveness of glucagon-like peptide-1 receptor agonists respectively sodium glucose co-transporter-2 inhibitors for mitochondrial diabetes is low. ijmhs [Internet]. 2020 Jun. 17 [cited 2024 Nov. 23];10(06):959-60. Available from: https://innovativejournal.in/index.php/ijmhs/article/view/2988